MiR-132-3p activation aggravates renal ischemia-reperfusion injury by targeting Sirt1/PGC1alpha axis.

[1]  B. Spiegelman,et al.  SnapShot: Regulation and biology of PGC-1α , 2022, Cell.

[2]  Meifang Wu,et al.  Advances in miR-132-Based Biomarker and Therapeutic Potential in the Cardiovascular System , 2021, Frontiers in Pharmacology.

[3]  F. Luo,et al.  Bioactive Peptide F2d Isolated from Rice Residue Exerts Antioxidant Effects via Nrf2 Signaling Pathway , 2021, Oxidative medicine and cellular longevity.

[4]  F. Cheng,et al.  miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway. , 2021, International immunopharmacology.

[5]  M. Fabbri,et al.  Noncoding RNA therapeutics — challenges and potential solutions , 2021, Nature reviews. Drug discovery.

[6]  M. Sperandio,et al.  AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction. , 2021, Journal of the American College of Cardiology.

[7]  G. Szabo,et al.  Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice , 2021, Molecular therapy. Nucleic acids.

[8]  Youhua Liu,et al.  MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of NLRP3 inflammasome. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  Zhiya Deng,et al.  SIRT1 attenuates sepsis-induced acute kidney injury via Beclin1 deacetylation-mediated autophagy activation , 2021, Cell Death & Disease.

[10]  R. Qi,et al.  Paeoniflorin Resists H2O2-Induced Oxidative Stress in Melanocytes by JNK/Nrf2/HO-1 Pathway , 2020, Frontiers in Pharmacology.

[11]  M. Mayr,et al.  Preclinical development of a miR-132 inhibitor for heart failure treatment , 2020, Nature Communications.

[12]  E. Rhee,et al.  NAD+ homeostasis in renal health and disease , 2019, Nature Reviews Nephrology.

[13]  Md Jamal Uddin,et al.  PGC‐1α, a potential therapeutic target against kidney aging , 2019, Aging cell.

[14]  Takafumi Suzuki,et al.  Molecular Mechanism of Cellular Oxidative Stress Sensing by Keap1. , 2019, Cell reports.

[15]  V. Popov,et al.  Regulation of Mitochondrial Biogenesis as a Way for Active Longevity: Interaction Between the Nrf2 and PGC-1α Signaling Pathways , 2019, Front. Genet..

[16]  M. Bhasin,et al.  TFEB-driven lysosomal biogenesis is pivotal for PGC1α-dependent renal stress resistance , 2019, JCI insight.

[17]  N. Nahman,et al.  MicroRNA-668 represses MTP18 to preserve mitochondrial dynamics in ischemic acute kidney injury , 2018, The Journal of clinical investigation.

[18]  S. Tullius,et al.  Improving the Supply and Quality of Deceased‐Donor Organs for Transplantation , 2018, The New England journal of medicine.

[19]  A. Benigni,et al.  Sirtuins in Renal Health and Disease. , 2018, Journal of the American Society of Nephrology : JASN.

[20]  P. Igarashi,et al.  microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism , 2017, Nature Communications.

[21]  T. Rabelink,et al.  Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation. , 2016, Kidney international.

[22]  A. Józkowicz,et al.  Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism , 2016, Cellular and Molecular Life Sciences.

[23]  Peng-Yuan Liu,et al.  MicroRNA-489 Induction by Hypoxia-Inducible Factor-1 Protects against Ischemic Kidney Injury. , 2016, Journal of the American Society of Nephrology : JASN.

[24]  M. Bhasin,et al.  PGC1α-dependent NAD biosynthesis links oxidative metabolism to renal protection , 2016, Nature.

[25]  R. Raju,et al.  Sirtuin regulation in aging and injury. , 2015, Biochimica et biophysica acta.

[26]  Naoki Nakagawa,et al.  Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. , 2015, The Journal of clinical investigation.

[27]  E. van Rooij,et al.  MicroRNA-24 antagonism prevents renal ischemia reperfusion injury. , 2014, Journal of the American Society of Nephrology : JASN.

[28]  C. Legendre,et al.  Delayed kidney graft function: from mechanism to translation. , 2014, Kidney international.

[29]  R. Schnellmann,et al.  Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia-reperfusion injury. , 2013, Toxicology and applied pharmacology.

[30]  C. Hao,et al.  The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. , 2013, Kidney international.

[31]  Z. Dong,et al.  Mouse model of ischemic acute kidney injury: technical notes and tricks. , 2012, American journal of physiology. Renal physiology.

[32]  M. Bhasin,et al.  PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. , 2011, The Journal of clinical investigation.

[33]  S. Biswal,et al.  Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress , 2011, Biochemical and biophysical research communications.

[34]  J. Iacomini,et al.  Identification of a microRNA signature of renal ischemia reperfusion injury , 2010, Proceedings of the National Academy of Sciences.

[35]  Z. Dong,et al.  Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. , 2010, Journal of the American Society of Nephrology : JASN.

[36]  M. Crow,et al.  Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. , 2009, Kidney international.

[37]  Johan Auwerx,et al.  PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure , 2009, Current opinion in lipidology.

[38]  P. Puigserver,et al.  Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.

[39]  Y. Bai,et al.  Effect of miR-132-3p on sepsis-induced acute kidney injury in mice via regulating HAVCR1/KIM-1. , 2021, American journal of translational research.

[40]  H. Bergmeister,et al.  miR-182-5p Inhibition Ameliorates Ischemic Acute Kidney Injury. , 2017, The American journal of pathology.

[41]  A. Cuadrado,et al.  Heme-Oxygenase I and PCG-1α Regulate Mitochondrial Biogenesis via Microglial Activation of Alpha7 Nicotinic Acetylcholine Receptors Using PNU282987. , 2017, Antioxidants & redox signaling.

[42]  Yunchao Su,et al.  Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6. , 2017, Kidney international.

[43]  H. S. Marinho,et al.  Activation of Nrf2 by H2O2: de novo synthesis versus nuclear translocation. , 2013, Methods in enzymology.